Olivia Belbin

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 21

Top Venues

Nature medicine

Alzheimer's research & therapy

Neurology

Molecular neurodegeneration

Hospital de la Santa Creu i Sant Pau Institut de Recerca

University of Nottingham (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Hospital de la Santa Creu i Sant Pau Institut de Recerca

Spain

Miguel Servet Type II Senior Associate Investigator :: Neurology

Hospital de la Santa Creu i Sant Pau Institut de Recerca

Spain

Miguel Servet Type I Senior Associate Investigator :: Neurology

Hospital de la Santa Creu i Sant Pau Institut de Recerca

Spain

Juan de la Cierva Senior Post-doctoral Research Fellow :: Neurology

Mayo Clinic Florida

United States

Post-Doctoral Investigator :: Neuroscience

Mayo Clinic Florida

United States

Post-Doctoral Investigator :: Neuroscience

University of Nottingham

United Kingdom

Research Network Administrator :: Molecular Medical Sciences

Education History

University of Nottingham

United Kingdom

PHD :: Molecular Medical Sciences

Publications

Juan Fortea, Jordi Pegueroles, Daniel Alcolea, Olivia Belbin, Oriol Dols-Icardo, Lídia Vaqué-Alcázar, Laura Videla, Juan Domingo Gispert, Marc Suarez-Calvet, Sterling C Johnson, Reisa A Sperling, Alexandre Bejanin, Alberto Lleó, Victor Montal
APOE4 homozygozity represents a distinct genetic form of Alzheimer's disease. Nature medicine 30 (5) (2024)
Juan Fortea, Jordi Pegueroles, Daniel Alcolea, Olivia Belbin, Oriol Dols-Icardo, Lídia Vaqué-Alcázar, Laura Videla, Juan Domingo Gispert, Marc Suarez-Calvet, Sterling C Johnson, Reisa A Sperling, Alexandre Bejanin, Alberto Lleó, Victor Montal
APOE4 homozygozity represents a distinct genetic form of Alzheimer's disease. Nature medicine (2024)
Juan Fortea, Jordi Pegueroles, Daniel Alcolea, Olivia Belbin, Oriol Dols-Icardo, Lídia Vaqué-Alcázar, Laura Videla, Juan Domingo Gispert, Marc Suarez-Calvet, Sterling C Johnson, Reisa A Sperling, Alexandre Bejanin, Alberto Lleó, Victor Montal
Publisher Correction: APOE4 homozygosity represents a distinct genetic form of Alzheimer's disease. Nature medicine (2024)
Sara E Zsadanyi, Alejandra O Morcillo-Nieto, Mateus R Aranha, Irina Aragón, José E Arriola-Infante, Lídia Vaqué-Alcázar, Victor Montal, Jordi Pegueroles, Javier Arranz, Íñigo Rodríguez-Baz, Lucia M Blesa, Laura Videla, Isabel Barroeta, Laura Del Hoyo Soriano, Bessy Benejam, Susana Fernández, Aida S Hernandez, Nuria Bargallo, Sofía González-Ortiz, Sandra Giménez, Daniel Alcolea, Olivia Belbin, Alberto Lleó, Juan Fortea, Maria Carmona-Iragui, Alexandre Bejanin
Associations of Microbleeds and Their Topography With Imaging and CSF Biomarkers of Alzheimer Pathology in Individuals With Down Syndrome. Neurology 103 (4) (2024)
Juan Fortea, Jordi Pegueroles, Daniel Alcolea, Olivia Belbin, Oriol Dols-Icardo, Lídia Vaqué-Alcázar, Laura Videla, Juan Domingo Gispert, Marc Suarez-Calvet, Sterling C Johnson, Reisa A Sperling, Alexandre Bejanin, Alberto Lleó, Victor Montal
APOE4 homozygozity represents a distinct genetic form of Alzheimer's disease. Nature medicine 30 (5) (2024)
Juan Fortea, Jordi Pegueroles, Daniel Alcolea, Olivia Belbin, Oriol Dols-Icardo, Lídia Vaqué-Alcázar, Laura Videla, Juan Domingo Gispert, Marc Suarez-Calvet, Sterling C Johnson, Reisa A Sperling, Alexandre Bejanin, Alberto Lleó, Victor Montal
APOE4 homozygozity represents a distinct genetic form of Alzheimer's disease. Nature medicine 30 (5) (2024)
Juan Fortea, Jordi Pegueroles, Daniel Alcolea, Olivia Belbin, Oriol Dols-Icardo, Lídia Vaqué-Alcázar, Laura Videla, Juan Domingo Gispert, Marc Suarez-Calvet, Sterling C Johnson, Reisa A Sperling, Alexandre Bejanin, Alberto Lleó, Victor Montal
APOE4 homozygozity represents a distinct genetic form of Alzheimer's disease. Nature medicine 30 (5) (2024)
Juan Fortea, Jordi Pegueroles, Daniel Alcolea, Olivia Belbin, Oriol Dols-Icardo, Lídia Vaqué-Alcázar, Laura Videla, Juan Domingo Gispert, Marc Suarez-Calvet, Sterling C Johnson, Reisa A Sperling, Alexandre Bejanin, Alberto Lleó, Victor Montal
APOE4 homozygozity represents a distinct genetic form of Alzheimer's disease. Nature medicine 30 (5) (2024)
Juan Fortea, Jordi Pegueroles, Daniel Alcolea, Olivia Belbin, Oriol Dols-Icardo, Lídia Vaqué-Alcázar, Laura Videla, Juan Domingo Gispert, Marc Suarez-Calvet, Sterling C Johnson, Reisa A Sperling, Alexandre Bejanin, Alberto Lleó, Victor Montal
APOE4 homozygozity represents a distinct genetic form of Alzheimer's disease. Nature medicine 30 (5) (2024)
Sara E Zsadanyi, Alejandra O Morcillo-Nieto, Mateus R Aranha, Irina Aragón, José E Arriola-Infante, Lídia Vaqué-Alcázar, Victor Montal, Jordi Pegueroles, Javier Arranz, Íñigo Rodríguez-Baz, Lucia M Blesa, Laura Videla, Isabel Barroeta, Laura Del Hoyo Soriano, Bessy Benejam, Susana Fernández, Aida S Hernandez, Nuria Bargallo, Sofía González-Ortiz, Sandra Giménez, Daniel Alcolea, Olivia Belbin, Alberto Lleó, Juan Fortea, Maria Carmona-Iragui, Alexandre Bejanin
Associations of Microbleeds and Their Topography With Imaging and CSF Biomarkers of Alzheimer Pathology in Individuals With Down Syndrome. Neurology 103 (4) (2024)
Juan Fortea, Lídia Vaqué-Alcázar, Jordi Pegueroles, Daniel Alcolea, Olivia Belbin, Oriol Dols-Icardo, Laura Videla, Juan Domingo Gispert, Marc Suarez-Calvet, Sterling C Johnson, Reisa A Sperling, Alexandre Bejanin, Alberto Lleó, Victor Montal
Reply to: Challenges to identifying risk versus protective factors in Alzheimer's disease. Nature medicine (2024)
Juan Fortea, Jordi Pegueroles, Daniel Alcolea, Olivia Belbin, Oriol Dols-Icardo, Lídia Vaqué-Alcázar, Laura Videla, Juan Domingo Gispert, Marc Suarez-Calvet, Sterling C Johnson, Reisa A Sperling, Alexandre Bejanin, Alberto Lleó, Victor Montal
APOE4 homozygozity represents a distinct genetic form of Alzheimer's disease. Nature medicine 30 (5) (2024)
Maria Florencia Iulita, Alexandre Bejanin, Eduard Vilaplana, Maria Carmona-Iragui, Bessy Benejam, Laura Videla, Isabel Barroeta, Susana Fernández, Miren Altuna, Jordi Pegueroles, Victor Montal, Silvia Valldeneu, Sandra Giménez, Sofía González-Ortiz, Soraya Torres, Shaimaa El Bounasri El Bennadi, Concepcion Padilla, Mateus Rozalem Aranha, Teresa Estellés, Ignacio Illán-Gala, Olivia Belbin, Natalia Valle-Tamayo, Valle Camacho, Esther Blessing, Ricardo S Osorio, Sebastian Videla, Sylvain Lehmann, Anthony J Holland, Henrik Zetterberg, Kaj Blennow, Daniel Alcolea, Jordi Clarimón, Shahid H Zaman, Rafael Blesa, Alberto Lleó, Juan Fortea
Association of biological sex with clinical outcomes and biomarkers of Alzheimer's disease in adults with Down syndrome. Brain communications 5 (2) (2023)
Julie Goossens, Alba Cervantes González, Nele Dewit, Laia Lidón, Juan Fortea, Daniel Alcolea, Alberto Lleó, Olivia Belbin, Eugeen Vanmechelen
Evaluation of cerebrospinal fluid levels of synaptic vesicle protein, VAMP-2, across the sporadic Alzheimer's disease continuum. Alzheimer's research & therapy 15 (1) (2023)
Alba Cervantes González, David J Irwin, Daniel Alcolea, Corey T McMillan, Alice Chen-Plotkin, David Wolk, Sònia Sirisi, Oriol Dols-Icardo, Marta Querol-Vilaseca, Ignacio Illán-Gala, Miguel Angel Santos-Santos, Juan Fortea, Edward B Lee, John Q Trojanowski, Murray Grossman, Alberto Lleó, Olivia Belbin
Multimarker synaptic protein cerebrospinal fluid panels reflect TDP-43 pathology and cognitive performance in a pathological cohort of frontotemporal lobar degeneration. Molecular neurodegeneration 17 (1) (2022)
Alba Cervantes González, Olivia Belbin
Fluid markers of synapse degeneration in synucleinopathies. Journal of neural transmission (Vienna, Austria : 1996) 129 (2) (2022)
Daniel Alcolea, Constance Delaby, Laia Muñoz, Soraya Torres, Teresa Estellés, Nuole Zhu, Isabel Barroeta, María Carmona-Iragui, Ignacio Illán-Gala, Miguel Ángel Santos-Santos, Miren Altuna, Isabel Sala, Mª Belén Sánchez-Saudinós, Laura Videla, Sílvia Valldeneu, Andrea Subirana, Jordi Pegueroles, Christophe Hirtz, Jérôme Vialaret, Sylvain Lehmann, Jonathan M Schott, Nicholas James Ashton, Kaj Blennow, Henrik Zetterberg, Olivia Belbin, Rafael Blesa, Jordi Clarimón, Juan Fortea, Alberto Lleó
Use of plasma biomarkers for AT(N) classification of neurodegenerative dementias. Journal of neurology, neurosurgery, and psychiatry 92 (11) (2021)
Alberto Lleó, Maria Carmona-Iragui, Laura Videla, Susana Fernández, Bessy Benejam, Jordi Pegueroles, Isabel Barroeta, Miren Altuna, Silvia Valldeneu, Mei-Fang Xiao, Desheng Xu, Raúl Núñez-Llaves, Marta Querol-Vilaseca, Sònia Sirisi, Alexandre Bejanin, M Florencia Iulita, Jordi Clarimón, Rafael Blesa, Paul Worley, Daniel Alcolea, Juan Fortea, Olivia Belbin
VAMP-2 is a surrogate cerebrospinal fluid marker of Alzheimer-related cognitive impairment in adults with Down syndrome. Alzheimer's research & therapy 13 (1) (2021)
Alberto Lleó, Henrik Zetterberg, Jordi Pegueroles, Jonathan M Schott, María Carmona-Iragui, Nicholas J Ashton, Victor Montal, Isabel Barroeta, Juan Lantero-Rodriguez, Laura Videla, Miren Altuna, Bessy Benejam, Susana Fernandez, Silvia Valldeneu, Diana Garzón, Alexandre Bejanin, Maria Florencia Iulita, Valle Camacho, Santiago Medrano-Martorell, Olivia Belbin, Jordi Clarimon, Sylvain Lehmann, Daniel Alcolea, Rafael Blesa, Kaj Blennow, Juan Fortea
Phosphorylated tau181 in plasma as a potential biomarker for Alzheimer's disease in adults with Down syndrome. Nature communications 12 (1) (2021)
Olivia Belbin, Mei-Fang Xiao, Desheng Xu, Maria Carmona-Iragui, Jordi Pegueroles, Bessy Benejam, Laura Videla, Susana Fernández, Isabel Barroeta, Raúl Nuñez-Llaves, Victor Montal, Eduard Vilaplana, Miren Altuna, Jordi Clarimón, Daniel Alcolea, Rafael Blesa, Alberto Lleó, Paul F Worley, Juan Fortea
Cerebrospinal fluid profile of NPTX2 supports role of Alzheimer's disease-related inhibitory circuit dysfunction in adults with Down syndrome. Molecular neurodegeneration 15 (1) (2020)
Alberto Lleó, Raúl Núñez-Llaves, Daniel Alcolea, Cristina Chiva, Daniel Balateu-Paños, Martí Colom-Cadena, Gemma Gomez-Giro, Laia Muñoz, Marta Querol-Vilaseca, Jordi Pegueroles, Lorena Rami, Albert Lladó, José L Molinuevo, Mikel Tainta, Jordi Clarimón, Tara Spires-Jones, Rafael Blesa, Juan Fortea, Pablo Martínez-Lage, Raquel Sánchez-Valle, Eduard Sabidó, Àlex Bayés, Olivia Belbin
Changes in Synaptic Proteins Precede Neurodegeneration Markers in Preclinical Alzheimer's Disease Cerebrospinal Fluid. Molecular & cellular proteomics : MCP 18 (3) (2019)

Olivia Belbin.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Olivia Belbin